Advanced Stent Technologies, Inc.
This article was originally published in The Gray Sheet
Executive Summary
Pleasanton, California firm will enroll 30 patients at four U.S. centers following FDA approval of a feasibility study evaluating the SLK-View side-access stent for cardiovascular bifurcation disease. The device uses a single-balloon delivery system with a take-off angle of as much as 80 degrees and the ability to register and post-dilate a stent side-hole without deforming the stent structure in the main branch of the artery, AST says. Outside the U.S., the firm expects a CE mark for the SLK-View in the second quarter of 2002...